🌍·1d agodiscovery
Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer
Publisher
T
The Manila Times
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- The Manila Times
- Region
- Global
- Scope
- discovery
- Published
- June 23, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: The Manila Times
Scope: discovery
Related coverage
More related coverage
Investing.com/4h ago
West Pharmaceutical Services stock hits 52-week high at $338.73
CoStar/4h ago
News | Pharmaceutical giant plans more than $1 billion expansion in Jacksonville, Florida
statnews.com/4h ago
At BIO, a glimpse behind Lilly and Chai’s partnership
GlobeNewswire/4h ago